Fortune Medical Solutions

Rasburicase, a recombinant urate oxidase enzyme that breaks down uric acid to hydrophilic allantoin and hydrogen peroxide, is approved by the various regulatory authorities for the prophylaxis and treatment of hyperuricemia during chemotherapy in adults and children with lymphoma, leukemia, and solid tumors.